Essilor Group A.I CyberSecurity Scoring
14/03/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Essilor Group in 2026.
No incidents recorded for Essilor Group in 2026.
No incidents recorded for Essilor Group in 2026.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com. See community guidelines here: bit.ly/4vTpKjz
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Latest updates, reports, and threat intel affecting the global network.
This report argues that EssilorLuxottica's path to AI supremacy is built upon a series of compounding, defensible advantages that its competitors
by: Tycko & Zavareei Whistleblower Practice Group, Tycko & Zavareei LLP - Thought Leadership: Our Attorneys Speak.
EssilorLuxottica IT EyeCare demonstrates compliance with requirements for ISO27001 standards and controls of the ISO27701 guideline global...
EssilorLuxottica, the world's largest eyewear group, has acquired Israeli startup Nuance Hearing. The deal, which was completed in late 2022.
Get the chance to grow with us and design your own career adventure. Take a step into EssilorLuxottica and be part of our international community.
Department of Justice settled two civil fraud cases against an optical lens manufacturer, marketer, and distributor Essilor regarding...
The winners and finalists in our seventh annual Corporate Counsel Awards, brought to you by the Dallas-Fort Worth chapter of the Association of Corporate...
Requesting a user or organization profile page (`GET /{username}`) with an `Accept: application/rss+xml` or `Accept: application/atom+xml` header returned the owner's activity feed without the visibility check that the profile page and the `.rss` and `.atom` routes apply. Anonymous users, restricted users and non-members could confirm the existence of limited or private users and private organizations and read their profile details and public activity, also when `[other] ENABLE_FEED` was disabled. Activity in private repositories was not included.
The Gitea API endpoint for creating push mirrors (`POST /api/v1/repos/{owner}/{repo}/push_mirrors`) checked only whether mirroring was enabled and not the `[mirror] DISABLE_NEW_PUSH` setting that the web interface enforces. A repository administrator could therefore create new push mirrors on instances where the site administrator had disabled them. A push mirror pushes all refs of the repository to a remote chosen by the caller, on each commit or on a schedule.
The Gitea API endpoint `GET /api/v1/repos/{owner}/{repo}/media/{filepath}` wrote files of up to 1 KiB that are stored directly in Git, not in LFS, to the response without the content type and disposition headers Gitea uses for user content. An HTML file committed to a repository was therefore rendered by the browser on the Gitea origin. A user who can push to a repository could run JavaScript in the session of a victim who opens the media URL and act with the victim's permissions.
With `[repository] FORCE_PRIVATE = true`, Gitea creates new repositories as private, but the post-receive hook still applied the `repo.private=false` push option to an empty repository created by push. Any user who can create repositories could make their new repository public in violation of the instance policy. The default configuration is not affected.
The Gitea push mirror API checked whether the repository owner, instead of the requesting user, may use local file system paths. On instances with `[security] IMPORT_LOCAL_PATHS = true`, a repository administrator who is not allowed to import local paths could add a push mirror to a local path on the server when the repository owner has that permission. Gitea then pushed the repository's refs into an existing Git repository at that path with the permissions of the Gitea process.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.